Skip to main content
Premium Trial:

Request an Annual Quote

Genomind Raises $6M in Funding Round

NEW YORK (GenomeWeb) – Mental health-focused genetic testing firm Genomind today said that it closed a $6 million funding round.

The latest investment bid was led by Claritas Capital, which led a $5 million financing round for Genomind in April 2014.

In a statement, Genomind said it plans to use the infusion of funds to grow the firm, conduct multisite randomized trials for the Genecept Assay pharmacogenetic service, and develop a new, expanded test offering. 

Genecept analyzes a panel of genes associated with mental health patients' ability to respond to drugs for depression, anxiety, ADHD, bipolar disorder, PTSD and schizophrenia. Researchers from Genomind last year published a cost-effectiveness study which found that using the Genecept Assay to guide treatment decisions made patients more adherent to medications, which increased pharmacy costs but lowered total medical outpatient services costs, compared to controls.

The Scan

Latent HIV Found in White Blood Cells of Individuals on Long-Term Treatments

Researchers in Nature Microbiology find HIV genetic material in monocyte white blood cells and in macrophages that differentiated from them in individuals on HIV-suppressive treatment.

Seagull Microbiome Altered by Microplastic Exposure

The overall diversity and the composition at gut microbiome sites appear to coincide with microplastic exposure and ingestion in two wild bird species, according to a new Nature Ecology and Evolution study.

Study Traces Bladder Cancer Risk Contributors in Organ Transplant Recipients

In eLife, genome and transcriptome sequencing reveal mutation signatures, recurrent somatic mutations, and risky virus sequences in bladder cancers occurring in transplant recipients.

Genes Linked to White-Tailed Jackrabbits' Winter Coat Color Change

Climate change, the researchers noted in Science, may lead to camouflage mismatch and increase predation of white-tailed jackrabbits.